Abstract
We surveyed 10,024 Australians regarding COVID-19 vaccine willingness. Overall, 59.9% indicated yes, 13.9% no and 26.3% unsure/don’t know. Vaccine willingness was higher in males, and increased with increasing education and socioeconomic advantage. Results contrast with earlier, smaller Australian surveys regarding vaccination willingness and confirm the need for targeted vaccination information.
Competing Interest Statement
For the research reported in this manuscript, all authors declare independent research funding from AstraZeneca, GlaxoSmithKline and Novartis. For work outside the manuscript, HKR declares honoraria for giving independent medical education at symposia funded by AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Sanofi and Teva, for participation on advisory boards for AstraZeneca, Chiesi, GlaxoSmithKline, Novartis and Sanofi, and for consultancy for Novartis. HKR is Chair of the Global Initiative for Asthma (GINA) Science Committee, and a member of the Australian Asthma Handbook Guidelines Committee
Funding Statement
GlaxoSmithKline Australia, AstraZeneca Australia and Novartis Australia provided funding to the Australian Centre for Airways disease Monitoring to support a National Breathlessness Survey from which these data were drawn.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Sydney Human Research Ethics Committee (Ref No: 2019/621, The National Breathlessness Survey)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data can be made available after Human Ethics Review Committee approval of an analyses plan.
